Stream 1: Health Economics & Innovation

 

[1] Evidence to Inform Biopharmaceutical Policy: Call for Research on the Impact of Public Policies on Investment in Drug Development (with K. Axelsen and S. Ezell) [Health Affairs Scholar]

 

[2] Evaluating the Impact of Genome Sequencing on Healthcare Resource Use: Evidence from Cancer Patients in the English National Health Service (working paper, with J. Buchanan, J. Buckell, and S. Wordsworth)

 

[3] Measuring Biopharmaceutical Innovation: A Proposed Rubric (working paper, under review at Nature Reviews Drug Discovery, with S. Kang, F. David, and S. Chang)

 

[4] Innovation in the Biopharmaceutical Industry: Slowing Down or Shifting Focus? (working paper, with S. Kang)